Corporate news announcement processed and transmitted by Hugin AS.
The issuer is solely responsible for the content of this 
announcement. 
----------------------------------------------------------------------
--------------    




At the  Extraordinary  General Meeting  that  took place  today,  the
shareholders of BB MEDTECH AG approved  the proposal of the Board  of
Directors to cancel 1  450 000 shares that  were acquired during  the
course of the third share buy-back program. As a result of this,  the
share capital will be reduced from CHF 29 000 000 to CHF 26 100 000.

It was also decided to carry  out a fourth share buy-back program  in
order to limit the discount of  BB MEDTECH in a sustained manner  and
to reduce it further. In accordance with the proposed share  buy-back
program, up to 10% of treasury shares,  i.e. up to 1 305 000  shares,
can be redeemed via a second trading line on the SIX Swiss  Exchange.
At one of the  forthcoming General Meetings,  the Board of  Directors
will propose a capital reduction that is equivalent to the volume  of
shares redeemed. The share buy-back  will take place on November  17,
2008 and will continue until no later than November 16, 2011. Details
of the share buy-back program will be published in the "Neue  Zürcher
Zeitung" and  "Le  Temps",  as  well as  on  the  company's  website,
www.bbmedtech.com.

Swiss Valor/ISIN number/Ticker symbol:
Registered shares in BB MEDTECH with a nominal value of CHF 2 each
3839001 / CH0038390016 / MEDN

Registered shares in BB  MEDTECH with a nominal  value of CHF 2  each
(share buy-back - second trading line)
2 605 089 / CH0026050895 / MEDEE




For further information, please contact:
Bellevue Asset Management AG, Seestrasse 16, CH-8700 Küsnacht/Zurich
Michael Hutter, Tel. +41 44 267 67 00


 
--- End of Message ---

BB MEDTECH AG
Vordergasse 3 Schaffhausen Switzerland

WKN: AONFN4; 
ISIN: CH0038390016; Index: IGSP;
Listed: Investment Companies in SWX Swiss Exchange;
http://hugin.info/130286/R/1270031/281066.pdf


Copyright © Hugin AS 2008. All rights reserved.